The overexpression of urokinase plasminogen activator (uPA) and its receptor (uPAR) is detected in various malignancies. Both in vitro and in vivo studies demonstrate that uPA/uPAR play an important role in tumor progression and metastasis. To define the mechanism responsible for high uPA/uPAR expression in invasive cancer cells, we previously showed that 1) the endogenous p38 MAPK activity is elevated in invasive cancer cells and is required for high uPA/uPAR expression; and 2) p38 MAPK maintains high uPA expression by promoting uPA mRNA stability. However, how p38 MAPK stabilizes uPA mRNA in invasive cancer cells remains unclear. In our preliminary studies, we identified an RNA-binding protein SECp43 that not only specifically interacts with p38a MAPK but also serves as a direct substrate of p38a MAPK in vitro. Overexpression of SECp43 destabilizes uPA mRNA while silencing SECp43 expression prolongs uPA mRNA half-life in p38 MAPK-inhibited condition, suggesting that SECp43 and p38a MAPK are functionally linked in regulating uPA mRNA stability. In further study, we found that SECp43 interacts with uPA mRNA stability in vivo and the region in uPA mRNA required for SECp43 interaction contains AU-rich element (ARE) motifs. Interestingly, we also found that cells with elevated p38 MAPK activity and uPA expression exhibit poor SECp43/uPA mRNA interaction and vice versa. These results suggest that p38a MAPK may stabilize uPA mRNA by impeding SECp43's ability to mediate uPA mRNA decay. This proposal seeks to capitalize on our previous work to 1) investigate how p38a MAPK regulates SECp43-mediated uPA mRNA decay; 2) determine the mechanisms involved in SECp43-mediated uPA mRNA turnover; and 3) determine how non-p38a-phosphorylable SECp43 affects tumor cell growth and metastasis. The proposed study should increase our understanding on p38 MAPK-mediated mRNA stabilization and mechanisms involved in elevated uPA/uPAR expression in invasive cancer cells. Also, gaining further understanding of the novel role of SECp43 in repressing uPA expression may lead to the development of a novel therapeutic approach to suppress tumor growth and metastasis. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA093926-05
Application #
7146004
Study Section
Tumor Progression and Metastasis Study Section (TPM)
Program Officer
Ault, Grace S
Project Start
2001-12-01
Project End
2007-05-31
Budget Start
2006-07-20
Budget End
2007-05-31
Support Year
5
Fiscal Year
2006
Total Cost
$302,878
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Hu, Q; Lu, Y-Y; Noh, H et al. (2013) Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression. Oncogene 32:3933-43
Hong, Sungguan; Noh, Hyangsoon; Chen, Haoming et al. (2013) Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs. Sci Signal 6:ra16
Chen, Huijun; Wu, Xufeng; Pan, Zhixing K et al. (2010) Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis. Cancer Res 70:9979-90
Li, Yong; Zhang, Maoxiang; Chen, Huijun et al. (2010) Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res 70:7894-904
Su, S; Li, Y; Luo, Y et al. (2009) Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration. Oncogene 28:3047-57
Chen, Haoming; Zhu, Genfeng; Li, Yong et al. (2009) Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res 69:9228-35
Mahanivong, C; Chen, H M; Yee, S W et al. (2008) Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene 27:1273-80
Mahanivong, Chitladda; Yu, Jianqiang; Huang, Shuang (2007) Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Mol Carcinog 46:165-75
Bian, D; Mahanivong, C; Yu, J et al. (2006) The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration. Oncogene 25:2234-44
Jing, Qing; Huang, Shuang; Guth, Sabine et al. (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120:623-34

Showing the most recent 10 out of 13 publications